Compass Therapeutics

Compass Therapeutics

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-368
-370
EBITDA
-26,783
-24,778
-17,949
-15,346
EBIT
-27,171
-25,154
-18,317
-15,716
Net Income
-27,171
-25,154
-18,317
-15,716
Net Change In Cash
0
0
0
0
Free Cash Flow
-16,423
-13,593
-17,351
-13,254
Cash
41,469
35,453
55,168
30,643
Basic Shares
186,798
186,798
186,400
184,844

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$0
$850
$0
$0
Gross Profit
-1,472
850
-1,890
-1,904
EBITDA
-65,017
-47,622
-40,604
-34,961
EBIT
-66,489
-49,375
-42,494
-36,865
Net Income
-66,489
-49,375
-42,494
-39,225
Net Change In Cash
0
850
0
0
Cost of Revenue
-109,568
Free Cash Flow
-49,168
-44,899
-40,648
-34,337
Cash
30,643
43,483
24,228
34,946
Basic Shares
157,695
137,108
127,027
105,186

Earnings Calls

QuarterEPS
2026-09-30
-$0.15
2026-06-30
-$0.13
2026-03-31
-$0.10
2025-12-31
-$0.09